Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
about
A network map of Interleukin-10 signaling pathwaySerum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case-control study.Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal typeExpression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.Role of interleukin 10 transcriptional regulation in inflammation and autoimmune diseaseCarcinogenicity testing of IL-10: principles and practicalities.Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targetsHuman cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)Stat4-dependent, T-bet-independent regulation of IL-10 in NK cellsSTAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.Cell type-specific regulation of IL-10 expression in inflammation and disease.Pathology and biology of peripheral T-cell lymphomas.Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3.Differential cytokine expression in EBV positive peripheral T cell lymphomas.An animal model for anaplastic large cell lymphoma in the immunocompetent syngeneic C57Bl/6 mouse.Immune escape mechanisms in ALCL.Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism.Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.Dendritic Cells Actively Limit Interleukin-10 Production Under Inflammatory Conditions via DC-SCRIPT and Dual-Specificity Phosphatase 4.CHIC cells: a novel ALK+ cell line derived from a relapsed anaplastic large cell lymphoma
P2860
Q28603589-D6060AF1-74B6-4C0C-8C36-CB2237E1B0C8Q33561191-EDC621D0-D765-4515-9154-E8BD3B3452D0Q33677463-A8A7D38A-551D-44E9-A57F-471F6CEA61E2Q33929834-5AC4F8F5-E232-4B6F-AF04-898624CFED94Q34262223-EDF87DC2-CD9A-4C95-B4BD-5627BAE64A8EQ34880596-5677F438-BC56-4462-8D52-7508D48B64B1Q34898306-4D063687-F60A-46EC-88FB-B24EFD01F049Q37113833-02A13859-1DFD-480E-B4B8-AEC9A468A576Q37210723-38608F6E-DFBE-4FE8-B918-F2486E73CC16Q37485330-91965590-E7A2-413C-A54E-AD1135EE7E99Q37678256-33324D15-B459-4727-92B7-06998B624A47Q37831955-AD125438-2AFD-40D8-82C1-E03B6808C92CQ40225147-EDA66F7F-794B-4C4F-BAE9-85B728CE434AQ40794864-5B797920-DFB2-4EE9-A8A0-699D76026254Q40846740-54F734C9-5EAC-4CA0-976E-99962EBF0B6DQ43011113-BEA22C7F-D895-4040-B775-48C5CF5640B1Q45737471-CCF50DFB-9780-4A89-B837-98C0AD8A39CBQ45960706-2D79F522-38E0-4CB1-BAAA-906A36543658Q53573964-F1A37D45-1CF0-4566-82BF-A05825FE2660Q55514821-098AAD9F-9A15-4F8E-98DD-922E75B78752Q57580311-F5A0BCAA-B76B-4177-9436-DCBF6D474005
P2860
Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Human interleukin-10 expressio ...... natural killer-cell lymphomas.
@ast
Human interleukin-10 expressio ...... natural killer-cell lymphomas.
@en
type
label
Human interleukin-10 expressio ...... natural killer-cell lymphomas.
@ast
Human interleukin-10 expressio ...... natural killer-cell lymphomas.
@en
prefLabel
Human interleukin-10 expressio ...... natural killer-cell lymphomas.
@ast
Human interleukin-10 expressio ...... natural killer-cell lymphomas.
@en
P2093
P2860
P1476
Human interleukin-10 expressio ...... natural killer-cell lymphomas.
@en
P2093
C Copie-Bergman
K Leroy-Viard
M L Boulland
P Kanavaros
P2860
P304
P356
10.1016/S0002-9440(10)65667-2
P407
P577
1998-10-01T00:00:00Z